PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26429394-5	2016	METHODS: In the current study we investigated the potential for AKR1C3 to regulate the availability of prostaglandin-derived ligands for PPARg mainly, prostaglandin J2 (PGJ2).	9-deoxy-delta-9-prostaglandin D2	151-167	aldo-keto reductase family 1 member C3	Homo sapiens	64-70	
30012349-4	2019	By acting as an 11-ketoprostaglandin reductase, AKR1C3 generates 11beta-PGF2alpha to activate the FP receptor and deprives peroxisome proliferator activator receptorgamma of its putative PGJ2 ligands.	9-deoxy-delta-9-prostaglandin D2	187-191	aldo-keto reductase family 1 member C3	Homo sapiens	48-54	
26429394-5	2016	METHODS: In the current study we investigated the potential for AKR1C3 to regulate the availability of prostaglandin-derived ligands for PPARg mainly, prostaglandin J2 (PGJ2).	9-deoxy-delta-9-prostaglandin D2	169-173	aldo-keto reductase family 1 member C3	Homo sapiens	64-70	
20036328-8	2010	MCF-7-AKR1C3 cells also reduced PGD(2), limiting its dehydration to form PGJ(2) products.	9-deoxy-delta-9-prostaglandin D2	73-79	aldo-keto reductase family 1 member C3	Homo sapiens	6-12	
24287039-7	2013	PPARgamma agonist (PGJ2) and antagonist (T0070907) enhanced PGFS mRNA abundance in the endometrium on days 10-12 and 14-16 of pregnancy, respectively.	9-deoxy-delta-9-prostaglandin D2	19-23	aldo-keto reductase family 1 member C3	Homo sapiens	60-64